{
    "Trade/Device Name(s)": [
        "ACCU-CHEK Aviva Plus Blood Glucose Monitoring System",
        "ACCU-CHEK Aviva Meter",
        "ACCU-CHEK Aviva Plus Test Strip",
        "ACCU-CHEK Aviva Control Solutions",
        "ACCU-CHEK Aviva Combo System",
        "ACCU-CHEK Spirit Combo Insulin Pump",
        "ACCU-CHEK 360\u00b0 Insulin Pump Configuration Software",
        "ACCU-CHEK Aviva Combo Meter"
    ],
    "Submitter Information": "Roche Diagnostics Corporation",
    "510(k) Number": "K131029",
    "Predicate Device Reference 510(k) Number(s)": [
        "K101299",
        "K111353"
    ],
    "Regulatory Class": "Class II",
    "Product Code(s)": [
        "NBW",
        "LFR",
        "LZG",
        "NDC"
    ],
    "Summary Letter Date": "August 9, 2013",
    "Summary Letter Received Date": "July 10, 2013",
    "Submission Date": "July 8, 2013",
    "Regulation Number(s)": [
        "21 CFR 862.1345",
        "21 CFR 880.5725",
        "21 CFR 868.1890"
    ],
    "Regulation Name(s)": [
        "Glucose test system",
        "Pump, infusion, insulin",
        "Drug dosing calculator"
    ],
    "Analyte Class(es)": [
        "chemistry",
        "endocrine"
    ],
    "Analyte(s)": [
        "Glucose"
    ],
    "Specimen Type(s)": [
        "Fresh capillary whole blood"
    ],
    "Specimen Container(s)": [
        ""
    ],
    "Instrument(s)/Platform(s)": [
        "ACCU-CHEK Aviva Meter",
        "ACCU-CHEK Aviva Combo Meter",
        "ACCU-CHEK Spirit Combo Insulin Pump"
    ],
    "Method(s)/Technology(ies)": [
        "Glucose dehydrogenase enzymatic measurement",
        "Radio frequency communication (for pump control)"
    ],
    "Methodologies": [
        ""
    ],
    "Submission Type(s)": [
        "System",
        "Meter",
        "Test Strip",
        "Control Solution",
        "Insulin Pump",
        "Software"
    ],
    "Document Summary": "FDA 510(k) summary for ACCU-CHEK Aviva Plus and ACCU-CHEK Aviva Combo Systems for self-monitoring of blood glucose and insulin infusion management.",
    "Indications for Use Summary": "For quantitative measurement of glucose in fresh capillary whole blood samples for self-testing and management of diabetes, and for subcutaneous delivery of insulin in persons requiring insulin.",
    "fda_folder": "Clinical Chemistry"
}